Bank of America’s $289 target on ABBV

ABBV AbbVie

$262 → $289 (+10%) by Sep 2027

Buy · raises · said Sep 30, 2026 · 12-month default horizon

Open: judged on the close on Sep 30, 2027

The article this target came from

BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength

AOL.com · Sep 30, 2026

BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength

Bank of America’s track record → AbbVie →

A fact about what Bank of America published, as reported by AOL.com, not a recommendation from Dalsna Finance; Bank of America is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.